A piperazine-substituted phthalocyanine with rapid cellular uptake and dual organelle-targeting for in vitro photodynamic therapy

Photodiagnosis Photodyn Ther. 2023 Dec:44:103818. doi: 10.1016/j.pdpdt.2023.103818. Epub 2023 Oct 1.

Abstract

The rational design of photosensitizers with rapid cellular uptake and dual-organelle targeting ability is essential for enhancing the efficacy of photodynamic therapy (PDT). However, achieving this goal is a great challenge. In this paper, a novel axial piperazine substituted (PIP) silicon phthalocyanine (PIP-SiPc) has been synthesized. The PIP substitution significantly improved the cellular uptake of PIP-SiPc in MCF-7 breast cancer cells, as demonstrated by two-photon fluorescence imaging combined with fluorescence correlation spectroscopy. Additionally, PIP-SiPc was able to target both mitochondria and lysosomes simultaneously. Notably, PIP-SiPc exhibited remarkable singlet oxygen generation ability, leading to apoptosis in cancer cells upon irradiation, with an IC50 value of only 0.2 µM. These findings highlight the effectiveness of PIP-SiPc as a multifunctional photosensitizer for PDT.

Keywords: Organelle targeting; Photodynamic therapy; Photosensisitizer; Phthalocyanine; Piperazine; Rapid cellular uptake.

MeSH terms

  • Humans
  • Isoindoles*
  • Mitochondria
  • Nicotinic Acids*
  • Photochemotherapy* / methods
  • Photosensitizing Agents* / chemistry
  • Photosensitizing Agents* / pharmacology
  • Piperazines / pharmacology
  • Succinimides*

Substances

  • Photosensitizing Agents
  • phthalocyanine
  • N-succinimidyl-5-iodo-3-pyridinecarboxylic acid
  • Piperazines
  • Nicotinic Acids
  • Succinimides
  • Isoindoles